Davide Conte

Davide Conte

Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori

Affiliated withFondazione IRCCS Istituto Nazionale dei Tumori

Research Area

Biography

Davide Conte has not added Biography.
If you are Davide Conte and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
Publication title

Cited by 34

2017

Other Publications

Article
Year
Molecular changes track recurrence and progression of bronchial precancerous lesions.

Lung cancer (Amsterdam, Netherlands)| PubMed ID: 12234694

2002
p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 12473590

2002
Quantification of free circulating DNA as a diagnostic marker in lung cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 14507943

2003
Detecting lung cancer in plasma with the use of multiple genetic markers.

International journal of cancer| PubMed ID: 14618621

2004
2005
2006
2005
Three-dimensional organization of the hepatic artery terminal branches: a scanning electron microscopic study of vascular corrosion casts of rat liver.

Italian journal of anatomy and embryology = Archivio italiano di anatomia ed embriologia| PubMed ID: 17580655

2007
Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study.

American journal of respiratory and critical care medicine| PubMed ID: 18787214

2009
Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project.

American journal of respiratory and critical care medicine| PubMed ID: 19096006

2009
EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues.

The American journal of pathology| PubMed ID: 19147828

2009
2009
2009
2010
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 21300873

2011
2011
Inactivation of both FHIT and p53 cooperate in deregulating proliferation-related pathways in lung cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer| PubMed ID: 22425911

2012
2012
Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 24419137

2014
Assessment of circulating microRNAs in plasma of lung cancer patients.

Molecules (Basel, Switzerland)| PubMed ID: 24619302

2014
2014
2015
Synergistic Activation upon MET and ALK Coamplification Sustains Targeted Therapy in Sarcomatoid Carcinoma, a Deadly Subtype of Lung Cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer| PubMed ID: 26804638

2016
Detection of microRNAs Using Chip-Based QuantStudio 3D Digital PCR.

Methods in molecular biology (Clifton, N.J.)| PubMed ID: 28439837

2017